Advertisement
UK markets closed
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • FTSE 250

    19,884.73
    +74.07 (+0.37%)
     
  • AIM

    743.26
    +1.15 (+0.15%)
     
  • GBP/EUR

    1.1707
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.2625
    +0.0003 (+0.02%)
     
  • Bitcoin GBP

    56,166.38
    +1,159.72 (+2.11%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • NIKKEI 225

    40,305.97
    +137.90 (+0.34%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • CAC 40

    8,205.81
    +1.00 (+0.01%)
     

BUZZ-Top of the Street: QinetiQ, Atlas Copco, Maersk, Shire

Aug 17 - A round-up of notable broker activity this morning from Europe's top-ranked* analysts:

** Following the stock's decline Barclays (LSE: BARC.L - news) upgrades QinetiQ to "overweight", believing that the balance of risk/reward is now favorably skewed

** In a note entitled "An attractive entry point" JPMorgan (LSE: JPIU.L - news) raises Atlas Copco (LSE: 0R82.L - news) to "overweight", expecting that a solid outlook in 2018 for Vacuum should ease a key investor concern

** Handelsbanken cuts A.P. Moller-Maersk to "sell", saying that the market estimates for Maersk Line are too optimistic and that pricing has gradually become too strained

ADVERTISEMENT

** Evercore initiates Shire (Xetra: S7E.DE - news) with "outperform", claiming that the key biologic franchises are well positioned for growth to offset hemophilia decline

(*Analyst rankings from Thomson Reuters StarMine. Scale is from 1-star to 5-star with 5 being best. Analysts ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)